Voyager

Showing 1 posts of 1 posts found.

abbviehqe_004_low

AbbVie turns to tau for Alzheimer’s in $1.1bn deal

February 21, 2018
Research and Development, Sales and Marketing AbbVie, Alzheimer's, Voyager, biotech, drugs, pharma, pharmaceutical

Sailing against the prevailing winds in the Alzheimer’s disease space, AbbVie has launched a deal worth a potential $1.1 billion …

The Gateway to Local Adoption Series

Latest content